Herantis Pharma Oyj Balance Sheet Health
Financial Health criteria checks 5/6
Herantis Pharma Oyj has a total shareholder equity of €2.0M and total debt of €30.0K, which brings its debt-to-equity ratio to 1.5%. Its total assets and total liabilities are €3.6M and €1.6M respectively.
Key information
1.5%
Debt to equity ratio
€30.00k
Debt
| Interest coverage ratio | n/a |
| Cash | €3.49m |
| Equity | €2.04m |
| Total liabilities | €1.61m |
| Total assets | €3.65m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: HRTIS's short term assets (€3.6M) exceed its short term liabilities (€1.6M).
Long Term Liabilities: HRTIS's short term assets (€3.6M) exceed its long term liabilities (€25.0K).
Debt to Equity History and Analysis
Debt Level: HRTIS has more cash than its total debt.
Reducing Debt: HRTIS's debt to equity ratio has reduced from 279.5% to 1.5% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: HRTIS has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: HRTIS has sufficient cash runway for 1.6 years if free cash flow continues to reduce at historical rates of 5.7% each year.